AI Science Tracker
EN

Using feature optimization and LightGBM algorithm to predict the clinical pregnancy outcomes after in vitro fertilization.

School of Basic Medicine, Anhui Medical University, Hefei, China.; Center of Reproductive Medicine, Children's Hospital of Shanxi and Women Health Center of Shanxi, Taiyuan, China.; School of Information, Shanxi University of Finance and Economics, Taiyuan, China. · 29 Nov 2023 · medicine

Discovery

Using feature optimization and LightGBM algorithm to predict the clinical pregnancy outcomes after in vitro fertilization.

Source check: Source checked. Not independent scientific confirmation.

Finding: Repeated five-fold cross-validation of IVF-cycle records selected LightGBM for pregnancy-outcome prediction (accuracy 92.31%, recall 87.80%, F1 90.00%, AUC 0.9041) and identified estrogen at HCG, endometrial thickness, infertility duration and BMI as important features. This is retrospective counseling evidence, not treatment-effect evidence. AI role: LightGBM with feature optimization. The article appeared in Frontiers In Endocrinology.

Technology: LightGBM with feature optimization

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
LightGBM with feature optimization
Test and result
Repeated five-fold cross-validation of IVF-cycle records selected LightGBM for pregnancy-outcome prediction (accuracy 92.31%, recall 87.80%, F1 90.00%, AUC 0.9041) and identified estrogen at HCG, endometrial thickness, infertility duration and BMI as important features. This is retrospective counseling evidence, not treatment-effect evidence.
Limitation / still unknown
The result is limited to the described dataset, cohort, experimental system, or validation design; generalization beyond that scope and downstream real-world benefit are not established. Author affiliation was not stated in the reviewed abstract or metadata.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2023.1305473/full · https://pubmed.ncbi.nlm.nih.gov/38093967/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.